Okuno, K.; Xu, C.; Pascual-Sabater, S.; Tokunaga, M.; Takayama, T.; Han, H.; Fillat, C.; Kinugasa, Y.; Goel, A.
Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Biomedicines 2023, 11, 119.
https://doi.org/10.3390/biomedicines11010119
AMA Style
Okuno K, Xu C, Pascual-Sabater S, Tokunaga M, Takayama T, Han H, Fillat C, Kinugasa Y, Goel A.
Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Biomedicines. 2023; 11(1):119.
https://doi.org/10.3390/biomedicines11010119
Chicago/Turabian Style
Okuno, Keisuke, Caiming Xu, Silvia Pascual-Sabater, Masanori Tokunaga, Tetsuji Takayama, Haiyong Han, Cristina Fillat, Yusuke Kinugasa, and Ajay Goel.
2023. "Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma" Biomedicines 11, no. 1: 119.
https://doi.org/10.3390/biomedicines11010119
APA Style
Okuno, K., Xu, C., Pascual-Sabater, S., Tokunaga, M., Takayama, T., Han, H., Fillat, C., Kinugasa, Y., & Goel, A.
(2023). Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Biomedicines, 11(1), 119.
https://doi.org/10.3390/biomedicines11010119